• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back
What does a normal endothelial cell release?
- EDRF: Endothelium-derived relaxing factor
- t-PA:PAI-1: Tissue plasminogen activator
- EDRF: Endothelium-derived relaxing factor
- t-PA:PAI-1: Tissue plasminogen activator
What is the normal action of EDRF (endothelium-derived relaxing factor)? Normal or dysfunctional?
Normal endothelial cell function:
- Inhibits platelet adhesion
- Promotes vasodilation
- Controls shear
- Prevents leukocyte adhesion
Normal endothelial cell function:
- Inhibits platelet adhesion
- Promotes vasodilation
- Controls shear
- Prevents leukocyte adhesion
What is the normal action of t-PA:PAI-1 (tissue plasminogen activator)? Normal or dysfunctional?
Normal endothelial cell function:
- Promotes fibrinolysis
Normal endothelial cell function:
- Promotes fibrinolysis
What does a dysfunctional endothelial cell release in hypercholesterolemia and atherosclerosis?
- Decreased EDRF: Endothelium-derived relaxing factor
- Decreased t-PA:PAI-1: Tissue plasminogen activator
- Increase in Adhesion Molecules
- Decreased EDRF: Endothelium-derived relaxing factor
- Decreased t-PA:PAI-1: Tissue plasminogen activator
- Increase in Adhesion Molecules
What are the results of a dysfunctional endothelial cell d/t hypercholesterolemia and atherosclerosis?
- ↓EDRF → platelet adhesion, vasoconstriction, ↑shear, leukocyte adhesion
- ↓t-PA:PAI-1 → promotes thrombosis
- ↑Adhesion molecules → monocyte and macrophage retention
- ↓EDRF → platelet adhesion, vasoconstriction, ↑shear, leukocyte adhesion
- ↓t-PA:PAI-1 → promotes thrombosis
- ↑Adhesion molecules → monocyte and macrophage retention
What causes endothelial dysfunction?
Cardiac Risk Factors → ↑Reactive Oxygen Species and ↑Inflammation
What does endothelial dysfunction cause?
Vascular remodeling and atherosclerosis → ↑risk of coronary events and stroke
What are some invasive ways to measure vascular health?
- Intra-coronary measures
- Peripheral venous plethysmography
What are some non-invasive ways to measure vascular health?
- Brachial artery reactivity
- Carotid IMT (intima media thickness)
- Vascular tonometry
Is brachial artery reactivity an invasive or non-invasive measure? What are you looking at in this screening?
- Non-invasive
- Use ultrasound to measure cross-section of brachial artery and can determine flow w/ doppler
- Changes in vessel diameter after cuff release are measured to determine percent flow mediated dilation
How do you do the brachial artery reactivity testing?
- Inflate BP cuff so that no blood can get through for 5 minutes
- Arm gets ischemic so the vessels dilate
- When you release cuff, flow velocity will be extremely fast, causing shear forces on vessel
- This should cause more dilation (peak 1-2 minutes after release)
* Measure absolute change in diameter and relative change in diameter: determines percent Flow Mediated Dilation (FMD)
How does the % Flow Mediated Dilation (FMD) change with BP?
- Optimal BP, greater FMD
- As BP worsens, FMD decreases
- Optimal BP, greater FMD
- As BP worsens, FMD decreases
How does your risk score (takes into account age, BP, CV disease, etc) predict your Flow Mediated Dilation (FMD)?
The higher your risk score, the lower your FMD
Does improving your Flow-Mediated Dilation with therapy affect your risk of having an adverse event?
- Improved FMD increases your chances of living adverse event free
- A persistently impaired FMD is associated with more adverse events
- Improved FMD increases your chances of living adverse event free
- A persistently impaired FMD is associated with more adverse events
What are the advantages of measuring Flow-Mediated Dilation?
- Non-invasive
- Uses a pervasive technology
- Correlates w/ function in coronary bed
- Correlates w/ CV outcomes
- Shows changes w/ therapy
- High sensitivity
What are the challenges of measuring Flow-Mediated Dilation?
- Technically difficult to perform (requires training)
- Protocol variations
- Requires significant off-line analysis
- No clear cut-off points for risk
- Minimal data with respect to clinical improvements w/ alteration
- Relatively low specificity
What does Carotid IMT measure?
Structural changes in intima-media thickness
Structural changes in intima-media thickness
What are some independent determinants of carotid IMT?
- Age
- Pulse pressure
- Diabetes
- LDL cholesterol
- Cigarette smoking
What are the advantages of measuring Carotid IMT?
- Relative ease of performance
- Pervasive technology
- Correlates w/ CV outcomes
- High sensitivity
- Correlates w/ presence and extent of coronary atherosclerosis
What are the challenges of measuring Carotid IMT?
- Variations by age, sex, and race
- Study heterogeneity
- Lack of specificity
- Minimal data with respect to improvements with alteration also improve outcomes